The Docosanoid Neuroprotectin D1 Induces TH-Positive Neuronal Survival in a Cellular Model of Parkinson’s Disease

Parkinson’s disease (PD) does not manifest clinically until 80 % of striatal dopamine is reduced, thus most neuronal damage takes place before the patient presents clinical symptoms. Therefore, it is important to develop preventive strategies for this disease. In the experimental models of PD, 1-met...

Descripción completa

Detalles Bibliográficos
Autores principales: Calandria, Jorgelina M., Sharp, Michelle W., Bazan, Nicolas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602058/
https://www.ncbi.nlm.nih.gov/pubmed/26047923
http://dx.doi.org/10.1007/s10571-015-0206-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602058/
https://www.ncbi.nlm.nih.gov/pubmed/26047923
http://dx.doi.org/10.1007/s10571-015-0206-6

Ejemplares similares